A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis
Bailey, Christine K, Caltabiano, Stephen, Cobitz, Alexander R, Huang, Chun, Mahar, Kelly M, Patel, Vickas V
Published in BMC nephrology (16.10.2019)
Published in BMC nephrology (16.10.2019)
Get full text
Journal Article
Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs
Mahar Doan, Kelly M, Humphreys, Joan E, Webster, Lindsey O, Wring, Stephen A, Shampine, Larry J, Serabjit-Singh, Cosette J, Adkison, Kimberly K, Polli, Joseph W
Published in The Journal of pharmacology and experimental therapeutics (01.12.2002)
Published in The Journal of pharmacology and experimental therapeutics (01.12.2002)
Get full text
Journal Article
Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposure
Caltabiano, Stephen, Cizman, Borut, Burns, Olivia, Mahar, Kelly M, Johnson, Brendan M, Ramanjineyulu, Bandi, Serbest, Gulyeter, Cobitz, Alexander R
Published in Clinical kidney journal (01.10.2019)
Published in Clinical kidney journal (01.10.2019)
Get full text
Journal Article
Survey of pharmaceutical industry's best practices around in vitro transporter assessment and Implications for Drug Development: Considerations from the IQ Transporter Working Group
Rollison, Helen E, Mitra, Pallabi, Chanteux, Hugues, Fang, Zhizhou, Liang, Xiaomin, Park, Seong Hee, Costales, Chester, Hanna, Imad, Thakkar, Nilay, Vergis, James M, Bow, Daniel A J, Hillgren, Kathleen M, Brumm, Jochen, Chu, Xiaoyan, Hop, Cornelis E C A, Lai, Yurong, Li, Cindy Yanfei, Mahar, Kelly M, Salphati, Laurent, Sane, Rucha, Shen, Hong, Taskar, Kunal, Taub, Mitchell E, Tohyama, Kimio, Xu, Christine, Fenner, Katherine S
Published in Drug metabolism and disposition (02.05.2024)
Published in Drug metabolism and disposition (02.05.2024)
Get full text
Journal Article
Comparison of Two Manufacturing Processes of Daprodustat for Bioequivalence and Dissolution in Healthy Volunteers: A Randomized Crossover Study
Shaddinger, Bonnie, Mahar, Kelly M., Sprys, Mike, Andrews, Susan M., Chattoraj, Sayantan, Israni, Rubeen, Cobitz, Alex
Published in Clinical pharmacology in drug development (01.07.2023)
Published in Clinical pharmacology in drug development (01.07.2023)
Get full text
Journal Article
Safety and efficacy of epelsiban in the treatment of men with premature ejaculation: a randomized, double-blind, placebo-controlled, fixed-dose study
Shinghal, Rajesh, Barnes, Allison, Mahar, Kelly M, Stier, Brendt, Giancaterino, Lisa, Condreay, Lynn D, Black, Libby, McCallum, Stewart W
Published in Journal of sexual medicine (01.10.2013)
Published in Journal of sexual medicine (01.10.2013)
Get more information
Journal Article
A Single‐Dose, Open‐Label, Randomized, Two‐Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat
Yamada, Masanori, Osamura, Minori, Ogura, Hirofumi, Onoue, Tomohiro, Wakamatsu, Akira, Numachi, Yotaro, Caltabiano, Stephen, Mahar, Kelly M.
Published in Clinical pharmacology in drug development (01.11.2020)
Published in Clinical pharmacology in drug development (01.11.2020)
Get full text
Journal Article
Randomized Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Topical Daprodustat in Healthy Volunteers and in Patients With Diabetic Foot Ulcers
Olson, Eric, Mahar, Kelly M., Morgan, Lisa, Fillmore, Christina, Holland, Claire, Lavery, Lawrence
Published in Clinical pharmacology in drug development (01.08.2019)
Published in Clinical pharmacology in drug development (01.08.2019)
Get full text
Journal Article
Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease
Olson, Eric, Demopoulos, Laura, Haws, Thomas F, Hu, Erding, Fang, Zixing, Mahar, Kelly M, Qin, Pu, Lepore, John, Bauer, Timothy A, Hiatt, William R
Published in Vascular medicine (London, England) (01.12.2014)
Published in Vascular medicine (London, England) (01.12.2014)
Get full text
Journal Article
Pharmacokinetics of Daprodustat and Metabolites in Individuals with Normal and Impaired Hepatic Function
Mahar, Kelly M., Shaddinger, Bonnie C., Ramanjineyulu, Bandi, Andrews, Susan, Caltabiano, Stephen, Lindsay, Alistair C., Cobitz, Alexander R.
Published in Clinical pharmacology in drug development (01.05.2022)
Published in Clinical pharmacology in drug development (01.05.2022)
Get full text
Journal Article
Clinical Pharmacokinetics of Daprodustat: Results of an Absorption, Distribution, and Excretion Study With Intravenous Microtracer and Concomitant Oral Doses for Bioavailability Determination
Mahar, Kelly M., Caltabiano, Stephen, Andrews, Susan, Ramanjineyulu, Bandi, Chen, Liangfu, Young, Graeme, Pereira, Adrian, Lindsay, Alistair C., van den Berg, Frans, Cobitz, Alexander R.
Published in Clinical pharmacology in drug development (01.12.2021)
Published in Clinical pharmacology in drug development (01.12.2021)
Get full text
Journal Article
The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects
Caltabiano, Stephen, Mahar, Kelly M., Lister, Karyn, Tenero, David, Ravindranath, Ramiya, Cizman, Borut, Cobitz, Alexander R.
Published in Pharmacology research & perspectives (01.04.2018)
Published in Pharmacology research & perspectives (01.04.2018)
Get full text
Journal Article
Single‐ and Multiple‐Day Dosing Studies to Investigate High‐Dose Pharmacokinetics of Epelsiban and Its Metabolite, GSK2395448, in Healthy Female Volunteers
Mahar, Kelly M., Enslin, Mary Beth, Gress, Angie, Amrine‐Madsen, Heather, Cooper, Melisa
Published in Clinical pharmacology in drug development (01.01.2018)
Published in Clinical pharmacology in drug development (01.01.2018)
Get full text
Journal Article
A Randomized, Placebo‐Controlled Trial to Assess the Effects of 8 Weeks of Administration of GSK256073, a Selective GPR109A Agonist, on High‐Density Lipoprotein Cholesterol in Subjects With Dyslipidemia
Olson, Eric J., Mahar, Kelly M., Haws, Thomas F., Fossler, Michael J., Gao, Feng, Gouville, Anne‐Charlotte, Sprecher, Dennis L., Lepore, John J.
Published in Clinical pharmacology in drug development (01.10.2019)
Published in Clinical pharmacology in drug development (01.10.2019)
Get full text
Journal Article
A single- and multiple-dose study to investigate the pharmacokinetics of epelsiban and its metabolite, GSK2395448, in healthy female volunteers
Mahar, Kelly M., Stier, Brendt, Fries, Michael, McCallum, Stewart W.
Published in Clinical pharmacology in drug development (01.11.2015)
Published in Clinical pharmacology in drug development (01.11.2015)
Get full text
Journal Article
Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma
Portnoy, Alison, Kumar, Sanjay, Behm, David J, Mahar, Kelly M, Noble, Robert B, Throup, John P, Russ, Steven F
Published in Frontiers in pharmacology (01.01.2013)
Published in Frontiers in pharmacology (01.01.2013)
Get full text
Journal Article